How to read a peptide test report (COA)

How to read a peptide test report (COA)

Guides / Storage, quality and routes

How to read a peptide test report (COA)

A certificate of analysis lists test results, but purity is not content, sterility is a separate test, and a report does not prove the vial you hold. Plain definitions plus real findings.

  • 9 sources
  • Not medical advice
A liquid chromatography instrument with a sample vial in its autosampler and a chromatogram on the monitor behind it
Illustration: a liquid chromatography instrument, the kind of equipment behind a purity test.

Short answer. A certificate of analysis (COA) is a report of test results for a batch. The main numbers are identity (is it the right molecule), purity (how much of what is there is the right molecule) and peptide content (how much of the powder is the peptide). Sterility and endotoxin are separate tests that a purity test does not cover. A COA from the seller is a claim. It becomes much stronger when an independent lab issued it and you can verify it with that lab.

On this page
    Marks on this page:SourcedOur reasoningNot establishedWhat these mean

    Why this matters, with real numbers

    A 2024 study in the Journal of Medical Internet Research (Ashraf, Mackey and colleagues) bought semaglutide products from online sellers without a prescription. Three vials arrived, and all three were judged probable substandard or falsified. Measured semaglutide purity was 7.7% to 14.4%, against 99% claimed. Content was 28.6% to 38.7% over the labeled amount. Endotoxin was detected in every sample. The three Ozempic pens the researchers ordered never arrived. It is a small sample from one product category, so it shows what can go wrong, not how often.

    The Victoria (Australia) Department of Health issued an alert on June 19, 2026 about six cases of acute liver toxicity since January 2026 linked to an unapproved product labeled as retatrutide. Contamination was suspected. The FDA’s page on unapproved GLP-1 drugs, updated October 1, 2026, reports dosing-error adverse events, some needing hospitalization.

    The lines on a COA, in plain words

    Line What it means What it does not tell you
    Identity (often mass spectrometry) The molecule’s weight matches the expected peptide That the vial contains enough of it, or is free of contaminants
    Purity (often HPLC, as a %) Of the peptide-related material that was detected, the share that is the target How much of the powder is peptide at all. Salts and water are not counted in this number
    Peptide content or net content The share of the dry powder by weight that is the peptide itself Whether it is pure
    Endotoxin Fever-causing bacterial fragments, tested separately Sterility
    Sterility Whether living microbes grow in a standard test Endotoxin or purity

    Purity is not content

    This is the most common misunderstanding. A synthetic peptide is usually made as a salt. Trifluoroacetic acid (TFA) is the main counterion in peptides made by common solid-phase synthesis, according to a 2025 consensus paper in Pharmaceuticals. A GenScript technical presentation says delivered peptide samples are typically only 50% to 80% target peptide by weight, with TFA often 10% to 30% of the weight and water usually under 10%. Another supplier, AmbioPharm, shows the arithmetic for theoretical net content and says actual values are measured by methods like amino acid analysis or elemental analysis.

    So a “99% pure” vial can still contain well under the labeled weight of actual peptide. The practical question is whether the label amount refers to total powder or to net peptide. The COA should say, and if it does not, that is a gap. These are supplier technical documents, not regulations.

    Sterility and endotoxin are different tests

    USP General Chapter <71> covers sterility testing and USP <85> covers the bacterial endotoxins test. They are separate chapters because they answer separate questions. A purity chromatogram does not show either one. If a COA lists only purity and mass, it says nothing about sterility or endotoxin. The USP chapter texts are behind a subscription, so we link to their official listings only.

    Whose COA is it?

    Under US drug manufacturing rules (21 CFR 211.84), a drug maker may accept a supplier’s report of analysis only if it also runs at least one identity test itself and validates the supplier’s results at appropriate intervals. The principle is simple: do not rely on the seller’s own paper alone. For a buyer, that points to some checks:

    • Is the lab independent of the seller?
    • Does the report carry a batch or lot number, and does it match the label on the vial?
    • Can you verify the report on the lab’s own site, rather than only as a PDF the seller sent?
    • Does it include a date and the test method?

    Even a perfect report covers the sample that was tested. It does not prove the vial in your hand came from that batch. Our reasoning

    Common questions

    What is the difference between purity and content?

    Purity is the share of detected peptide-related material that is the right molecule. Content is the share of the dry powder, by weight, that is peptide. Salts and water sit outside the purity number.

    Does a COA prove a vial is sterile?

    Only if it lists a sterility test. Sterility (USP <71>) and endotoxin (USP <85>) are separate tests from purity.

    Why does the lab behind a COA matter?

    A seller’s own report is a claim. In a 2024 study of online semaglutide, measured purity was 7.7% to 14.4% against 99% claimed.

    Keep reading

    Sources
    1. Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription (Ashraf et al.), J Med Internet Res 2024;26:e65440, JMIR
    2. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, FDA, updated October 1, 2026
    3. Toxicity linked to unapproved peptide product labelled Retatrutide, Victoria Department of Health, June 19, 2026
    4. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides (Erckes et al.), Pharmaceuticals 2025;18(8):1163, MDPI
    5. Examining the components of your peptide sample with AccuPep QC (Lu, 2015), GenScript, supplier technical presentation
    6. How is Theoretical Net Peptide Content Calculated?, AmbioPharm, supplier page
    7. USP <71> Sterility Tests, USP-NF (listing)
    8. USP <85> Bacterial Endotoxins Test, USP-NF (listing)
    9. 21 CFR 211.84 Testing and approval or rejection of components, eCFR

    Educational reference, not medical advice. This page describes what public health and regulatory sources say. It does not tell you what to take or do.